Literature DB >> 20011430

Laparoscopy in Crohn's disease.

Murali N Naidu1, Alfred C Trang, Barry A Salky.   

Abstract

Crohn's disease represents a challenging operative dilemma. The nature of the disease increases the technical complexity of operations, their morbidity, and the likelihood of multiple operations. In this setting, the advantages of laparoscopic surgery, including shorter hospital stays, less adhesion formation, fewer wound complications, and faster recovery of bowel function, are particularly beneficial to the patient. Patients with Crohn's disease requiring operations in the elective and semi-elective setting can all be approached initially laparoscopically. The surgeon's skill set should include extensive experience in advanced laparoscopic bowel surgery as well as open management of Crohn's disease and its complications. Strict adherence to the basic tenet of bowel preservation is imperative. The operations most commonly performed for Crohn's disease include diagnostic laparoscopy, stricturoplasty, small bowel resection, ileocolic resection, colectomy, repair of fistulae, and gastrojejunostomy for bypass of gastric or duodenal disease. Postoperative management includes resumption of steroids, typically without the need for "stress-dosing," bowel rest for a short period, and pain control, which is also less than that experienced with a laparotomy.

Entities:  

Keywords:  Crohn's disease; Laparoscopy; operative approach

Year:  2007        PMID: 20011430      PMCID: PMC2780224          DOI: 10.1055/s-2007-991033

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  16 in total

Review 1.  Management of Crohn's disease in adults.

Authors:  S B Hanauer; W Sandborn
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

2.  Advantages of laparoscopic resection for ileocolic Crohn's disease. Improved outcomes and reduced costs.

Authors:  T M Young-Fadok; K HallLong; E J McConnell; G Gomez Rey; R L Cabanela
Journal:  Surg Endosc       Date:  2001-04-03       Impact factor: 4.584

3.  Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease.

Authors:  J W Milsom; K A Hammerhofer; B Böhm; P Marcello; P Elson; V W Fazio
Journal:  Dis Colon Rectum       Date:  2001-01       Impact factor: 4.585

4.  Advantages of laparoscopic resection for ileocecal Crohn's disease.

Authors:  Hans-Joachim Duepree; Anthony J Senagore; Conor P Delaney; Karen M Brady; Victor W Fazio
Journal:  Dis Colon Rectum       Date:  2002-05       Impact factor: 4.585

5.  Laparoscopic-assisted vs. open ileocolic resection for Crohn's disease. A comparative study.

Authors:  W A Bemelman; J F Slors; M S Dunker; R A van Hogezand; S J van Deventer; J Ringers; G Griffioen; D J Gouma
Journal:  Surg Endosc       Date:  2000-08       Impact factor: 4.584

6.  Laparoscopically assisted intestinal resection in 88 patients with Crohn's disease.

Authors:  J Canin-Endres; B Salky; F Gattorno; M Edye
Journal:  Surg Endosc       Date:  1999-06       Impact factor: 4.584

7.  Laparoscopic ileocecal resection in Crohn's disease: a case-matched comparison with open resection.

Authors:  S Benoist; Y Panis; A Beaufour; Y Bouhnik; C Matuchansky; P Valleur
Journal:  Surg Endosc       Date:  2003-01-18       Impact factor: 4.584

8.  Laparoscopic vs conventional ileocolectomy for primary Crohn disease.

Authors:  Gregg Shore; Quintin H Gonzalez; Anthony Bondora; Selwyn M Vickers
Journal:  Arch Surg       Date:  2003-01

9.  The role of conversion in laparoscopic colorectal surgery: Do predictive factors exist?

Authors:  O Schwandner; T H Schiedeck; H Bruch
Journal:  Surg Endosc       Date:  1999-02       Impact factor: 4.584

10.  Laparoscopic surgery for recurrent Crohn's disease.

Authors:  H Hasegawa; M Watanabe; H Nishibori; K Okabayashi; T Hibi; M Kitajima
Journal:  Br J Surg       Date:  2003-08       Impact factor: 6.939

View more
  1 in total

1.  Robotic-assisted strictureplasty for Crohn's disease.

Authors:  S Tou; E Pavesi; A Nasser; P Mazirka; R Bergamaschi
Journal:  Tech Coloproctol       Date:  2015-01-08       Impact factor: 3.781

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.